title: Psychotropic medication and stroke outcome.
authors.forename: Chuan-Sheng
authors.initials: CS
authors.lastname: Zhao
authors.forename: Kirsi
authors.initials: K
authors.lastname: Puurunen
authors.forename: Juhani
authors.initials: J
authors.lastname: Sivenius
authors.forename: Jukka
authors.initials: J
authors.lastname: Jolkkonen
authors.forename: Timothy
authors.initials: T
authors.lastname: Schallert
mesh_terms: D000367:Age Factors; D000368:Aged; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003704:Dementia / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D008297:Male; D017063:Outcome Assessment, Health Care; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000627:therapeutic use; D051381:Rats; D018967:Risperidone / Q000009:adverse effects / Q000494:pharmacology; D020521:Stroke / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D011619:Psychotropic Drugs; D018967:Risperidone